ARCT
Arcturus Therapeutics Holdings Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom +7.6% ·
netto nieuwe posities -6.2%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 13.31K | $171,364 | n/a | n/a |
| Q2 2026 | 62 | +4 | 19.18M | $128.95M | +5 | −1 |
| Q1 2026 | 60 | 0 | 18.54M | $142.94M | +4 | −4 |
| Q4 2025 | 60 | 0 | 18.71M | $114.66M | +3 | −3 |
| Q3 2025 | 16 | -1 | 10.27M | $189.25M | +1 | −2 |
| Q2 2025 | 14 | +1 | 8.29M | $107.85M | +2 | −1 |
| Q1 2025 | 10 | +3 | 4.50M | $47.65M | +3 | n/a |
| Q4 2024 | 7 | -2 | 3.97M | $67.41M | n/a | −2 |
| Q3 2024 | 8 | -2 | 3.11M | $72.14M | n/a | −2 |
| Q2 2024 | 10 | n/a | 3.78M | $92.06M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ ×9 |
| 2 | The Vanguard Group ✦ (passief) | 1.89M | +4.2% | $34.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | ARK Investment Management ✦ | 1.87M | +9.2% | $34.51M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 1.05M | +2.5% | $19.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 704.88K | n/a | $12.99M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 6 | Geode Capital Management ✦ (passief) | 611.82K | +0.9% | $11.28M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Arrowstreet Capital ✦ | 552.18K | +1371.4% | $10.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 407.21K | n/a | $7.50M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | Goldman Sachs Group ✦ | 144.73K | n/a | $2.67M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Fidelity (FMR) ✦ | 133.88K | -26.3% | $2.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 89.22K | +3.3% | $1.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 85.48K | -23.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | D. E. Shaw & Co. ✦ | 60.21K | +476.9% | $1.11M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 42.12K | +46.9% | $776,272 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Millennium Management ✦ | 39.80K | Nieuw | $733,514 | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 27.95K | +20.1% | $516,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Millennium Management | $733,514 | 0.0% |
Verlaten
| AQR Capital Management | $145,946 | was 0.0% |
| Point72 Asset Management | $80,059 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 124 houders, 24.09M aandelen, $182.18M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.